Actualités L&g Multi-strategy Enhanced Commodities Ucits Etf - ENCO | Actions Italian Stock Exchange

Votre Hub pour des idées et discussions en direct en temps réel

Encorium Group, Inc. Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial W

Company Successful with its Strategic Focus on Vaccines and Oncology Trials BERWYN, Pa., Sept. 9 /PRNewswire-FirstCall/ -- Encorium Group, Inc...

Encorium Receives NASDAQ Deficiency Letter Regarding Stockholders' Equity

BERWYN, Pa., Aug. 31 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ:ENCO), a full service multinational clinical research organization...

Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10-Q Filing

WAYNE, Pa., Aug. 27 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ:ENCO), a full service multinational clinical research organization...

Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business

WAYNE, Pa., July 1 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full service multinational contract research organization...

Encorium Reports First Quarter 2009 Financial Results

Net Loss Significantly Reduced to $195,220 in First Quarter on Cost Cutting WAYNE, Pa., May 19 /PRNewswire-FirstCall/ -- Encorium Group, Inc...

Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business

WAYNE, Pa., May 18 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full service multinational contract research organization...

Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team

WAYNE, Pa., May 7 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full-service multinational contract research organization...

Encorium Announces Stock Buyback; Provides Business and Financial Update

WAYNE, Pa., Oct. 6 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full service multinational clinical research organization...

Encorium Announces Receipt of Nasdaq Letter Regarding Compliance with Nasdaq's Independent Director and Audit Committee Requirem

WAYNE, Pa., Oct. 1 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full service multinational clinical research organization...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

L&g Multi-strategy Enhanced Commodities Ucits Etf (ENCO)

Votre Hub pour des idées et discussions en direct en temps réel

ENCO Actualités

Encorium Group, Inc. Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial W

Encorium Receives NASDAQ Deficiency Letter Regarding Stockholders' Equity

Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10-Q Filing

Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business

Encorium Reports First Quarter 2009 Financial Results

Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business

Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team

Encorium Announces Stock Buyback; Provides Business and Financial Update

Encorium Announces Receipt of Nasdaq Letter Regarding Compliance with Nasdaq's Independent Director and Audit Committee Requirem

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

L&g Multi-strategy Enhanced Commodities Ucits Etf (ENCO) Actualités

L&g Multi-strategy Enhanced Commodities Ucits Etf (ENCO)

Votre Hub pour des idées et discussions en direct en temps réel

ENCO Actualités

Encorium Group, Inc. Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial W

Encorium Receives NASDAQ Deficiency Letter Regarding Stockholders' Equity

Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10-Q Filing

Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business

Encorium Reports First Quarter 2009 Financial Results

Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business

Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team

Encorium Announces Stock Buyback; Provides Business and Financial Update

Encorium Announces Receipt of Nasdaq Letter Regarding Compliance with Nasdaq's Independent Director and Audit Committee Requirem

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités